Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Goodwill & Intangibles: 2019-2024

Historic Goodwill & Intangibles for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to $34.9 million.

  • Eton Pharmaceuticals' Goodwill & Intangibles rose 444.55% to $31.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.9 million, marking a year-over-year increase of 444.55%. This contributed to the annual value of $34.9 million for FY2024, which is 636.04% up from last year.
  • Per Eton Pharmaceuticals' latest filing, its Goodwill & Intangibles stood at $34.9 million for FY2024, which was up 636.04% from $4.7 million recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Goodwill & Intangibles ranged from a high of $34.9 million in FY2024 and a low of $575,000 during FY2020.
  • In the last 3 years, Eton Pharmaceuticals' Goodwill & Intangibles had a median value of $4.8 million in 2022 and averaged $14.8 million.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first dropped by 20.69% in 2020, then surged by 636.04% in 2024.
  • Eton Pharmaceuticals' Goodwill & Intangibles (Yearly) stood at $575,000 in 2020, then soared by 529.74% to $3.6 million in 2021, then surged by 31.29% to $4.8 million in 2022, then declined by 0.32% to $4.7 million in 2023, then soared by 636.04% to $34.9 million in 2024.